Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy Journal:International Heart Journal | 2019 | 3 | ||
FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes Journal:Journal of Cellular and Molecular Medicine | 2020 | 3 | ||
Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis Journal:Journal of Cellular Physiology | 2020 | 8 |